Deconstructing data

Political Defibrillator

Although Steven Nissen's meta-analysis of safety data for diabetes drug Avandia rosiglitazone is flawed, that doesn't mean the drug has no cardiovascular risk. But quantifying the level of risk requires large-scale controlled studies, such as the ongoing RECORD study being run by GlaxoSmithKline plc. ...